February 28, 2017 / 8:10 AM / 6 months ago

Denmark's Novo raises holding in Evotec to 10.1 pct

FRANKFURT, Feb 28 (Reuters) - Denmark's Novo A/S has increased its holding in German biotech group Evotec AG to more than 10 percent, a regulatory filing showed on Tuesday.

Novo A/S, which controls Novo Nordisk, earlier this month acquired 8.9 percent of shares in Evotec via a capital increase.

As of Feb. 27, Novo A/S held 10.1 pct of shares in Evotec via investment vehicle Novo Nordisk Fonden, Tuesday's filing showed. (Reporting by Maria Sheahan; Editing by Victoria Bryan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below